Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Abbott India

Abbott India

BSE: 500488|NSE: ABBOTINDIA|ISIN: INE358A01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 23, 16:00
12677.70
-37 (-0.29%)
VOLUME 674
LIVE
NSE
Jan 23, 15:57
12707.90
5.7 (0.04%)
VOLUME 10,901
News on Abbott India
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Abbott India, target of Rs 540: LKP Shares

4.39 pm | 24 Nov 2008 |  Source: Moneycontrol.com

LKP Shares has recommended a buy rating on Abbott India with a price target of Rs 540. The research firm's believes that the debt-free Abbott India is...

Abbott India Aug qtr net profit at Rs 17.6 cr

9.36 am | 24 Sep 2008 |  Source: Moneycontrol.com

Abbott India has declared its results for the quarter ended August 31, 2008. The company's net profit for the quarter was at Rs 17.6 crore versus Rs 1...

Abbott India Q4 net profit at Rs 14.1 cr

9.10 am | 23 Jun 2008 |  Source: CNBC-TV18

Abbott India has declared its results for the quarter ended March 2008 (Q4). Its Q4 net profit was at Rs 14.1 crore versus Rs 12.9 crore....

Abbott Ind, Merck can deliver higher returns: Ranganathan  

4.12 pm | 26 Mar 2008 |  Source: CNBC-TV18

S Ranganathan, LKP Shares and Sec is of the view that Abbott India and Merck can deliver higher returns in terms of earnings growth much better than t...

Abbott India has target of Rs 630: G Shah 

3.52 pm | 25 Feb 2008 |  Source: CNBC-TV18

Gaurang Shah of Geojit Financial Services is of the view that Abbott India has target of Rs 630. It is a 65% subsidiary of Abbott Inc. USA. Abbott Ind...

Sun Pharma gets approval for Depakote delayed release tabs

12.22 pm | 15 Feb 2008

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the Companys Abbreviated New Drug Application for generic ...

Abbott Labs sues Sun Pharma over Divalproex patent rights

12.17 pm | 06 Feb 2008 |  Source: CNBC-TV18

Sun Pharma has been sued by Abbott Labs for patent rights of an anti-epilepsy drug, Divalproex ER, reports CNBC-TV18. Sun is also being sued by Forest...

1
Quick Links for Abbott India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.